Cargando…

Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma

We sought to identify a secreted biomarker for β-catenin activation commonly seen in hepatocellular carcinoma (HCC). By examination of our previously published genearray of hepatocyte-specific β-catenin knockout (KO) livers, we identified secreted factors whose expression may be β-catenin-dependent....

Descripción completa

Detalles Bibliográficos
Autores principales:	Okabe, Hirohisa, Delgado, Evan, Lee, Jung Min, Yang, Jing, Kinoshita, Hiroki, Hayashi, Hiromitsu, Tsung, Allan, Behari, Jaideep, Beppu, Toru, Baba, Hideo, Monga, Satdarshan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043833/ https://www.ncbi.nlm.nih.gov/pubmed/24892551 http://dx.doi.org/10.1371/journal.pone.0098817

Ejemplares similares

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis
por: Okabe, Hirohisa, et al.
Publicado: (2016)

Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
por: Beppu, Toru, et al.
Publicado: (2020)

Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis
por: Kulkarni, Uday, et al.
Publicado: (2015)

Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma
por: Chu, Tian-Huei, et al.
Publicado: (2022)

Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
por: He, Wen-Ming, et al.
Publicado: (2019)

Leukocyte Cell‐Derived Chemotaxin‐2: It's Role in Pathophysiology and Future in Clinical Medicine
por: Slowik, V, et al.
Publicado: (2017)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)

Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma
por: Higashi, Takaaki, et al.
Publicado: (2015)

Repeated hepatic resections and radio-frequency ablations may improve the survival of adult undifferentiated embryonal sarcoma of the liver: report of two cases
por: Masuda, Toshiro, et al.
Publicado: (2015)

Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy
por: Hayashi, Hiromitsu, et al.
Publicado: (2020)

Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report
por: Kaur, Gagandeep, et al.
Publicado: (2017)

Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice
por: Kikuchi, Akihiro, et al.
Publicado: (2020)

Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
por: Yoo, Hye Jin, et al.
Publicado: (2017)

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET
por: Shirasaki, Takayoshi, et al.
Publicado: (2022)

Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer
por: Sakamoto, Keita, et al.
Publicado: (2015)

Endothelial Wnts regulate β‐catenin signaling in murine liver zonation and regeneration: A sequel to the Wnt–Wnt situation
por: Preziosi, Morgan, et al.
Publicado: (2018)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
por: Koga, Yuki, et al.
Publicado: (2018)

Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis
por: Sak, Jarosław Jerzy, et al.
Publicado: (2021)

The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential
por: Zhu, Ming-Hui, et al.
Publicado: (2023)

Accessory right hepatic artery branched from gastroduodenal artery
por: Yamashita, Kohei, et al.
Publicado: (2015)

Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia
por: Tanisawa, Kumpei, et al.
Publicado: (2017)

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice
por: Okumura, Akinori, et al.
Publicado: (2017)

Mixed leukocyte cell-derived chemotaxin 2 and amyloid A renal amyloidosis in a Kazakh-German patient
por: Gödecke, Vega A., et al.
Publicado: (2017)

Transcriptional regulation of chicken leukocyte cell-derived chemotaxin 2 in response to toll-like receptor 3 stimulation
por: Lee, Seokhyun, et al.
Publicado: (2019)

Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2)
por: Ha, Jeung-Hoi, et al.
Publicado: (2021)

TGF-β1-Mediated Leukocyte Cell-Derived Chemotaxin 2 Is Associated With Liver Fibrosis in Biliary Atresia
por: Zhao, Jinfeng, et al.
Publicado: (2022)

EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation
por: Kuroki, Hideyuki, et al.
Publicado: (2014)

Successful surgical rescue of delayed onset diaphragmatic hernia following radiofrequency ablation using a thoracoscopic approach for hepatocellular carcinoma: a case report
por: Morito, Atsushi, et al.
Publicado: (2021)

Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system
Publicado: (1992)

New Markers in Atherosclerosis: Thrombospondin-2 (THBS-2) and Leukocyte Cell-Derived Chemotaxin-2 (LECT-2); An Immunohistochemical Study
por: Sonmez, Fatma Cavide, et al.
Publicado: (2016)

Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma
por: Yusa, Toshihiko, et al.
Publicado: (2022)

BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019)

β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
por: Krutsenko, Yekaterina, et al.
Publicado: (2021)

Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?
por: Huang, Hsien-Hao, et al.
Publicado: (2018)

A case of successful transarterial stenting for pseudoaneurysm after pancreaticoduodenectomy
por: Kitamura, Fumimasa, et al.
Publicado: (2020)

Melatonin promoted chemotaxins expression in lung epithelial cell stimulated with TNF-α
por: Luo, FengMing, et al.
Publicado: (2004)

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
por: Komori, Hiroyuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k5f3na5b3dheo9rvnf87ffk0n0